Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rainbow Childrens MedicareBOM:543524 -1.16%90 Altman Z-Score is 10.50 as of Aug. 10, 2026, which is 4% above its 10-year median of 10.05. GuruFocus rates BOM:543524 with a GF Score™ of 90/100 and a GF Value™ of ₹1,703.50 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Rainbow Childrens Medicare ranks better than 90.55% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 10.5 is strong.
Rainbow Childrens Medicare has a Altman Z-Score of 10.50, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Rainbow Childrens Medicare's Altman Z-Score or its related term are showing as below:
BOM:543524'
s Altman Z-Score Range Over the Past 10 Years
Min: 6.03 Med: 10.05 Max: 12.69
Current: 10.5
During the past 8 years, Rainbow Childrens Medicare's highest Altman Z-Score was 12.69. The lowest was 6.03. And the median was 10.05.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543524 vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Rainbow Childrens Medicare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainbow Childrens Medicare Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rainbow Childrens Medicare's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Rainbow Childrens Medicare's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Rainbow Childrens Medicare (BOM:543524) has a Altman Z-Score of 10.50 as of Aug. 10, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Rainbow Childrens Medicare and its competitors. This is near median its historical median of 10.05. Over the past decade, Rainbow Childrens Medicare's Altman Z-Score has ranged from 6.03 to 12.69. According to the industry distribution chart, Rainbow Childrens Medicare ranks #62 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 9.5%.
Is Rainbow Childrens Medicare's Altman Z-Score too high?
Rainbow Childrens Medicare's current Altman Z-Score of 10.50 is near median its 10-year median of 10.05. Over the past 10 years, this metric has ranged from a low of 6.03 to a high of 12.69. The Healthcare Providers & Services industry median Altman Z-Score is 2.42. Rainbow Childrens Medicare's value of 10.50 is 333.9% above this industry median. Based on the distribution chart, Rainbow Childrens Medicare ranks #62 out of 656 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Rainbow Childrens Medicare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rainbow Childrens Medicare's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rainbow Childrens Medicare ranks #62 out of 656 companies for Altman Z-Score. This places Rainbow Childrens Medicare in the top 10% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.42. Rainbow Childrens Medicare's value of 10.50 is 333.9% above this benchmark. Historically, Rainbow Childrens Medicare's own Altman Z-Score has ranged from 6.03 to 12.69 over the past decade. While the company's 10-year median is 10.05 vs. the industry median of 2.42, Rainbow Childrens Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.42, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rainbow Childrens Medicare's current Altman Z-Score of 10.50 is 333.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Rainbow Childrens Medicare and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainbow Childrens Medicare's current Altman Z-Score is 10.50, which is near median its own 10-year median of 10.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainbow Childrens Medicare stock overvalued right now?
Based on GuruFocus' analysis, Rainbow Childrens Medicare (BOM:543524) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,703.50, compared to a current price of ₹1,537.60 — trading 9.7% below its estimated fair value. The current Altman Z-Score is 10.50, which is near median its 10-year median of 10.05 and 333.9% above the Healthcare Providers & Services industry median of 2.42. Rainbow Childrens Medicare's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Rainbow Childrens Medicare (BOM:543524), the current Altman Z-Score is 10.50 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainbow Childrens Medicare (BOM:543524) Overvalued in 2026?
Based on GuruFocus' analysis, Rainbow Childrens Medicare stock appears to be undervalued.
The current stock price of ₹1,537.60 is trading 9.7% below its estimated GF Value™ of ₹1,703.50.
GuruFocus considers Rainbow Childrens Medicare to be Modestly Undervalued.
Key valuation signals for BOM:543524:
Altman Z-Score: 10.50 (near median its 10-year median of 10.05)
GF Value™: ₹1,703.50 vs. price of ₹1,537.60 (9.7% below fair value)
Industry Position: 333.9% above the Healthcare Providers & Services median (#62 of 656)
No single metric tells the full story. See the BOM:543524 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainbow Childrens Medicare Ltd operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology, which includes normal and complex obstetric care, and multidisciplinary fetal care, perinatal genetic and fertility care. Medical and Healthcare services have been considered the only reportable segment.
90GF Score
Get the complete analysis for BOM:543524
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543524 has been successfully added to your 
